| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
DEMANT Stock Overview
Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people’s hearing in Europe, North America, the Pacific, Asia, and internationally.
Demant Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.288.80 |
| 52 Week High | kr.394.70 |
| 52 Week Low | kr.248.70 |
| Beta | 0.94 |
| 1 Month Change | 2.41% |
| 3 Month Change | -1.40% |
| 1 Year Change | -18.88% |
| 3 Year Change | 41.50% |
| 5 Year Change | 71.40% |
| Change since IPO | 1,604.64% |
Recent News & Updates
Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate
Does the June share price for Demant A/S ( CPH:DEMANT ) reflect what it's really worth? Today, we will estimate the...
If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?
While Demant A/S ( CPH:DEMANT ) might not be the most widely known stock at the moment, it received a lot of attention...
Shareholder Returns
| DEMANT | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | 14.2% | 9.5% | 4.8% |
| 1Y | -18.9% | -31.4% | -1.2% |
Return vs Industry: DEMANT exceeded the Danish Medical Equipment industry which returned -31.4% over the past year.
Return vs Market: DEMANT underperformed the Danish Market which returned -1.2% over the past year.
Price Volatility
| DEMANT volatility | |
|---|---|
| DEMANT Average Weekly Movement | 6.4% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in DK Market | 10.9% |
| 10% least volatile stocks in DK Market | 3.5% |
Stable Share Price: DEMANT is not significantly more volatile than the rest of Danish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: DEMANT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 18,116 | Søren Nielsen | https://www.demant.com |
Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people’s hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products.
Demant Fundamentals Summary
| DEMANT fundamental statistics | |
|---|---|
| Market Cap | kr.63.65b |
| Earnings (TTM) | kr.2.51b |
| Revenue (TTM) | kr.18.39b |
25.3x
P/E Ratio3.5x
P/S RatioIs DEMANT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEMANT income statement (TTM) | |
|---|---|
| Revenue | kr.18.39b |
| Cost of Revenue | kr.4.57b |
| Gross Profit | kr.13.81b |
| Other Expenses | kr.11.30b |
| Earnings | kr.2.51b |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 16, 2022
| Earnings per share (EPS) | 11.40 |
| Gross Margin | 75.13% |
| Net Profit Margin | 13.67% |
| Debt/Equity Ratio | 115.5% |
How did DEMANT perform over the long term?
See historical performance and comparisonValuation
Is DEMANT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DEMANT?
Other financial metrics that can be useful for relative valuation.
| What is DEMANT's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | kr.63.65b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 4x |
| Enterprise Value/EBITDA | 19.6x |
| PEG Ratio | 2.9x |
Price to Earnings Ratio vs Peers
How does DEMANT's PE Ratio compare to its peers?
| DEMANT PE Ratio vs Peers |
|---|
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 42.8x |
Price-To-Earnings vs Peers: DEMANT is good value based on its Price-To-Earnings Ratio (25.3x) compared to the peer average (42.8x).
Price to Earnings Ratio vs Industry
How does DEMANT's PE Ratio compare vs other companies in the Medical Equipment Industry?
Price-To-Earnings vs Industry: DEMANT is good value based on its Price-To-Earnings Ratio (25.3x) compared to the Danish Medical Equipment industry average (29.8x)
Price to Earnings Ratio vs Fair Ratio
What is DEMANT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 25.3x |
| Fair PE Ratio | 30.3x |
Price-To-Earnings vs Fair Ratio: DEMANT is good value based on its Price-To-Earnings Ratio (25.3x) compared to the estimated Fair Price-To-Earnings Ratio (30.3x).
Share Price vs Fair Value
What is the Fair Price of DEMANT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DEMANT (DKK288.8) is trading below our estimate of fair value (DKK526.41)
Significantly Below Fair Value: DEMANT is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: DEMANT is poor value based on its PEG Ratio (2.9x)
Discover undervalued companies
Future Growth
How is Demant forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Future Growth Score
3/6Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
8.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DEMANT's forecast earnings growth (8.8% per year) is above the savings rate (0.09%).
Earnings vs Market: DEMANT's earnings (8.8% per year) are forecast to grow slower than the Danish market (9.3% per year).
High Growth Earnings: DEMANT's earnings are forecast to grow, but not significantly.
Revenue vs Market: DEMANT's revenue (7.2% per year) is forecast to grow faster than the Danish market (6.5% per year).
High Growth Revenue: DEMANT's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DEMANT's Return on Equity is forecast to be high in 3 years time (34.1%)
Discover growth companies
Past Performance
How has Demant performed over the past 5 years?
Past Performance Score
5/6Past Performance Score 5/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
2.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DEMANT has high quality earnings.
Growing Profit Margin: DEMANT's current net profit margins (13.7%) are higher than last year (7.7%).
Past Earnings Growth Analysis
Earnings Trend: DEMANT's earnings have grown by 2.2% per year over the past 5 years.
Accelerating Growth: DEMANT's earnings growth over the past year (124.2%) exceeds its 5-year average (2.2% per year).
Earnings vs Industry: DEMANT earnings growth over the past year (124.2%) exceeded the Medical Equipment industry 10.3%.
Return on Equity
High ROE: Whilst DEMANT's Return on Equity (31.68%) is high, this metric is skewed due to their high level of debt.
Discover strong past performing companies
Financial Health
How is Demant's financial position?
Financial Health Score
3/6Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: DEMANT's short term assets (DKK7.9B) do not cover its short term liabilities (DKK11.0B).
Long Term Liabilities: DEMANT's short term assets (DKK7.9B) exceed its long term liabilities (DKK5.9B).
Debt to Equity History and Analysis
Debt Level: DEMANT's net debt to equity ratio (100.8%) is considered high.
Reducing Debt: DEMANT's debt to equity ratio has increased from 78.9% to 115.5% over the past 5 years.
Debt Coverage: DEMANT's debt is well covered by operating cash flow (35.5%).
Interest Coverage: DEMANT's interest payments on its debt are well covered by EBIT (46.1x coverage).
Balance Sheet
Discover healthy companies
Dividend
What is Demant current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DEMANT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DEMANT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DEMANT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DEMANT's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as DEMANT has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
2.3yrs
Average management tenure
CEO
Søren Nielsen (51 yo)
6.75yrs
Tenure
kr.16,600,000
Compensation
Mr. Søren Nielsen has been the Chief Executive Officer and President of Demant A/S (formerly known as William Demant Holding A/S) since April 1, 2017 and has been its Member of Executive Board since Septem...
CEO Compensation Analysis
Compensation vs Market: Søren's total compensation ($USD2.35M) is about average for companies of similar size in the Danish market ($USD3.23M).
Compensation vs Earnings: Søren's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: DEMANT's management team is considered experienced (2.3 years average tenure).
Board Members
Experienced Board: DEMANT's board of directors are considered experienced (3.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Demant A/S's employee growth, exchange listings and data sources
Key Information
- Name: Demant A/S
- Ticker: DEMANT
- Exchange: CPSE
- Founded: 1904
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: kr.63.646b
- Shares outstanding: 220.38m
- Website: https://www.demant.com
Number of Employees
Location
- Demant A/S
- Kongebakken 9
- Smørum
- Capital Region of Denmark
- 2765
- Denmark
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/26 00:00 |
| End of Day Share Price | 2022/06/24 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.